Laurus Labs Limited Overview
Pro stress-test →Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad, with focus areas including active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology, veterinary APIs and agrochemicals. The company supplies APIs to nine of the 10 largest generic pharma companies in the world.
Strategic Profile
Pro stress-test →Laurus Synthesis is the company's CDMO subsidiary, with the US, European Union and Japan as the three most important markets. Laurus Labs has announced three major capacity expansions including a microbial fermentation facility in Vizag expected to go online by the end of 2026.
Competitive Landscape
Pro stress-test →Major competitors include Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, Cipla, Lupin, and Aarti Drugs. Laurus Labs differentiates through specialized CDMO capabilities, APIs for niche therapeutics (oncology, antiretrovirals), and global manufacturing footprint with strong regulatory approvals across multiple jurisdictions.
Industry Context
Laurus Labs Limited operates in Pharmaceuticals & Biotechnology (APIs, CDMOs, Generic Formulations).
Key facts
Founded: 2005 · Headquarters: Hyderabad, India · Employees: 12,467 · Revenue: $734M (TTM) · Market cap: $5.3B